Overview

Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

Status:
Unknown status
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether levetiracetam is safe and well tolerated by patients while suffering a status epilepticus. Levetiracetam is added to the standard treatment of patients with this disease.
Phase:
Phase 2
Details
Lead Sponsor:
Medical Center Haaglanden
Collaborator:
UCB Pharma
Treatments:
Etiracetam
Levetiracetam
Piracetam